Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients
Condition: Systemic Lupus Erythematosus Interventions: Biological: Telitacicept; Drug: Hydroxychloroquine; Drug: Prednisone; Drug: Methylprednisolone; Drug: Cyclophosphamide; Drug: Mycophenolate Mofetil; Drug: Tacrolimus Sponsor: Fen Li Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: China Health | Hydroxychloroquine | Methylprednisolone | Prednisone | Prograf | Research | Study | Tacrolimus